Feedback / Questions
plinabulin (BPI 2358) - BeyondSpring
https://www.globenewswire.com/news-release/2025/12/11/3203772/0/en/BeyondSpring-Announces-New-Analyses-of-DUBLIN-3-Phase-3-Study-Showing-Survival-Benefit-of-Plinabulin-Docetaxel-in-Post-Anti-PD-L-1-for-Non-squamous-EGFR-WT-NSCLC-and-a-Reduction-in.html
Dec 11, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next